Immunic

IMUX · NASDAQ

$7.41+$0.42 (+6.01%)TodayMarket closed ·
Prev close $6.99

Who owns IMUX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 46.2% of IMUX’s shares.

  • abrdn Inc.6.1%
  • BVF Partners L.P.5.6%
  • Millennium Management LLC5.4%
  • Avidity Partners Management LP4.9%
  • Next 6 largest institutions24.1%
  • All other shareholders53.8%
Top institutional holders of IMUX
HolderShares% of shares
abrdn Inc.824.39K6.05%
BVF Partners L.P.765.29K5.62%
Millennium Management LLC740.35K5.44%
Avidity Partners Management LP669.94K4.92%
Braidwell LP645.01K4.74%
Laurion Capital Management LP610.33K4.48%
Vanguard Capital Management, LLC571.56K4.20%
Jones Hill Capital LP539.81K3.96%
Woodline Partners LP471.53K3.46%
Soleus Capital Management, L.P.450.00K3.30%

Largest mutual fund holders

Top mutual fund holders of IMUX
HolderShares% of shares
abrdn Healthcare Investors Fund (US)473.88K3.48%
Vanguard Total Stock Market Index Fund399.09K2.93%
abrdn Life Sciences Investors302.89K2.22%
Vanguard Extended Market Index Fund159.25K1.17%
abrdn World Healthcare Fund47.63K0.35%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of IMUX in the last 6 months.

Latest IMUX insider transactions
InsiderTypeSharesValue
Nagel Robert ThorvaldAward25.37K—
BVF PARTNERS L P/ILAward25.37K—
Ridloff ElenaAward50.74K—
Skerjanec SimonaAward25.37K—
Rudick Richard AlanAward25.37K—
Neermann JoergAward25.37K—
Congleton JonAward25.37K—
PHILLIPS BARCLAY AAward25.37K—
Lundgren ErikAward1.00M—
Panzara Michael A.Award300.00K—

Short interest

Settled Sep 30, 2026

Shares short
2.08M
Days to cover
4.56
% of shares outstanding
15.24%
Average daily volume
455.37K
Change since last report
+15.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.